应用
选项
-
CD41a Mouse mAb关联靶标: ITGA2B简短描述: mAb (HIP8); Mouse anti Human CD41a Antibody; Flow; Unconjugated种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: HIP8 偶联: Unconjugated
-
I-A/I-E Rat mAb简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody; in vivo MHC II blockade, Functional assays, ICC, IF, WB, IP, Flow; Unconjugated种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Unconjugated
-
CD41a Mouse mAb (Biotin)关联靶标: ITGA2B简短描述: mAb (HIP8); Mouse anti Human CD41a Antibody (Biotin); Flow种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: HIP8 偶联: Biotin
-
CD41a Mouse mAb (FITC)关联靶标: ITGA2B简短描述: mAb (HIP8); Mouse anti Human CD41a Antibody (FITC); Flow种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: HIP8 偶联: FITC
-
CD41a Mouse mAb (PE)关联靶标: ITGA2B简短描述: mAb (HIP8); Mouse anti Human CD41a Antibody (PE); Flow种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: HIP8 偶联: PE
-
I-A/I-E Rat mAb (Biotin)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (Biotin); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Biotin
-
I-A/I-E Rat mAb (FITC)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (FITC); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: FITC
-
I-A/I-E Rat mAb (APC)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (APC); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Unconjugated
-
I-A/I-E Rat mAb (AF647)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (AF647); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: AF647
-
I-A/I-E Rat mAb (PE)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (PE); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: PE
-
I-A/I-E Rat mAb (PE-Cy5)关联靶标: HLA-DQB1简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (PE-Cy5); Flow Cytometry种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: PE-Cy5
-
I-A/I-E Rat mAb (PE-Cy7)关联靶标: HLA-DQB1简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (PE-Cy7); Flow Cytometry种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: PE-Cy7
首页
400-620-6333











